Ambassadors for Cancer Research
July 1, 2020 – Golden retriever owners Eric and Renee Chester talk about their hopes as participants in the Golden Retriever Lifetime Study
Displaying 41 - 50 of 226 results
Evaluating a Therapeutic Agent That May Inhibit a Protein Associated with Lymphoma
This study evaluates a new therapeutic agent designed to inhibit the survivin protein in canine lymphoma.
Using New Technology to Improve Diagnosis of Lymphoma in Cats
SUMMARY: Researchers will study the genes that are turned “on” and “off” in feline gastrointestinal lymphoma as a step toward improving the diagnosis of this important cancer.
Golden Retriever Lifetime Study Reaches 500 Diagnoses of 4 Major Cancers
July 26, 2023 — Morris Animal Foundation recently reached its goal of 500 cumulative diagnoses of four major canine cancers.
Phytomedicines Take on Cancer
April 26, 2022 – A new Foundation-funded study is analyzing the effects of parthenolide, derived from the feverfew plant, on different canine cancer cell lines.
Determining the Prognostic Value of Identifying Genetic Mutations in Dogs with Lymphoma
Researchers will assess the value of a genetic prognostic tool to assist with treatment decisions for dogs with diffuse large B-cell lymphoma.
60+ Years of Cancer Research
April 20, 2023 – The Foundation’s support for pet cancer research started back in the early 1960s, when little was known about the disease in animals or humans.
Episode 54: Environmental Toxins, Cancer and Pets
March 2, 2023 — Are there things pet parents can do to prevent cancer in their furry friends? Learn more in this latest episode of the Fresh Scoop podcast.
New Canine Study Investigates Cancers and Exposure to Environmental Chemicals
April 9, 2020 – New study looks at link between environmental chemicals and cancer in dogs.
Morris Animal Foundation Partners with Loyal to Study Dogs’ Genetic Changes that Occur as They Age
June 7, 2021 – We are partnering with Loyal to investigate how dogs’ biomarkers change throughout life and can be predictive of future health outcomes.